The '''Novartis Institute for Tropical Disease''' ('''NITD''') is a Singapore-based [[tropical disease]] [[research institute]] created through a [[public-private partnership]] between [[Novartis]] and the [[Singapore Economic Development Board]]. Research at NITD focuses primarily on developing novel [[small molecule]] therapies for tropical infectious diseases that are [[endemic (epidemiology)|endemic]] to the developing world, particularly [[dengue fever]], [[malaria]] and [[tuberculosis]].<ref name = about>{{Cite web | url = http://www.novartis.com/research/nitd/about.shtml | title = About NITD | accessdate = 2008-12-23 | year = 2008 | publisher = [[Novartis]] AG}}</ref><ref name = mission>{{Cite web | url = http://www.novartis.com/research/nitd/about/our-mission.shtml | title = Our mission | accessdate = 2008-12-23 | year = 2008 | publisher = [[Novartis]] AG}}</ref>

==History and mission==
NITD was founded in 2002 as a public-private partnership between Swiss-based pharmaceutical company [[Novartis]] and the [[Singapore Economic Development Board]].<ref name = about/>

NITD states its goals are "to discover novel [[therapy|treatment]]s and [[disease prevention|prevention]] methods for major [[tropical disease]]s." Their website states they hope to have at least two drug candidates going through [[clinical trial]]s in patients by the year 2012.<ref name = mission/>

Novartis has also stated that the NITD will seek to make treatments developed by the NITD available without profit to the poor in developing  nations in which these diseases are [[endemic (epidemiology)|endemic]].<ref>{{cite web | url = http://www.medadnews.com/News/Index.cfm?articleid=592713 |accessdate = 2008-12-23 | title = Commitment to Patients Earns Novartis' Dr. Daniel Vasella B'nai B'rith International's Highest Award | work = PharmaLive | publisher = Canon Communications Pharmaceutical Media Group  | date = 2008-12-15 | quote = Novartis has developed several programs aimed at enhancing affordability and access to treatment, including the Novartis Institute for Tropical Diseases, where Novartis researches novel treatments and prevention methods for neglected tropical diseases such as Dengue fever, and will make these available, without profit, to poor endemic countries. }}</ref>

==Research==
NITD is a [[small molecule]] [[drug discovery]] research institute.<ref name = about/>

Research is currently focused on three main diseases:<ref name = mission/>
*[[dengue fever]]
*[[malaria]]
*[[tuberculosis]].

NITD's research model relies on global partnership with other research institutes.<ref name = about/>
In 2008, NITD announced a 5-year collaborative research effort would be conducted in cooperation with the [[TB Alliance]] to develop new medicines for tuberculosis, including [[Multi-drug-resistant tuberculosis|drug resistant tuberculosis]].<ref name = "Moz TB">{{Cite web |url= http://www.novartis.com/downloads/research/nitd/newsroom/press_releases/nitd_mozambique_tb_september_2008.pdf |title= Novartis symposium in Mozambique tackles emerging tuberculosis challenges |accessdate=2008-12-23 |date= 2008-09-08 |format= media release |publisher= [[Novartis]] Global Communications |location= Basel, Switzerland |pages= 5 |quote= One of the core missions of the NITD is its commitment to improving access to medicines
and helping reduce the overall global TB disease burden. The NITD recently announced a
five-year research collaboration with the TB Alliance to develop new medicines for TB,
including drug-resistant strains.}}</ref>

==Education==
In addition to research, NITD is engaged in educational activities. It runs a research-based Master of Science program in fields related to infectious diseases in cooperation with [[National University of Singapore]], [[University of Basel]] and [[Swiss Tropical Institute]].<ref name = masters>{{Cite web | url = http://www.novartis.com/research/nitd/about/masters-degree-infectuous-diseases.shtml | title = Master of Science in infectious diseases, vaccinology and drug discovery | accessdate = 2008-12-23 | year = 2008 | publisher = [[Novartis]] AG}} {{Dead link|date=October 2010|bot=H3llBot}}</ref>

NITD also supports training opportunities for [[post-graduate]] students and [[post-doctoral]] fellows.<ref name = mission/>

==See also==
* [[Novartis Vaccines Institute for Global Health ]] at [[Siena|Siena, ITALY]]

==References==
{{Reflist}}

==External links==
*[http://www.nibr.com/research/developing_world/NITD/index.shtml NITD official website]

{{coord missing|Singapore}}

[[Category:Novartis]]
[[Category:Research institutes in Singapore]]
[[Category:2002 establishments in Singapore]]
[[Category:Tropical diseases]]
[[Category:Medical research institutes]]